Stock Analiz

Inspire Medical Systems, Inc. (INSP) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Inspire Medical Systems’s revenue went from $16M in fiscal 2016 to $912M in fiscal 2025, growth of about 56.3% a year.

Net income in fiscal 2025 was $145M, a net margin of 15.9%; the highest of the period.

Over the twelve months to September 30, 2026, revenue was $881M and net income $101M.

Free cash flow was $78M in fiscal 2025 and positive in 4 of the 10 years shown.

The diluted share count rose 2615% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $16M162017: $29M172018: $51M182019: $82M192020: $115M202021: $233M212022: $408M222023: $625M232024: $803M242025: $912M25$912M
Net income
2016: -$19M162017: -$18M172018: -$22M182019: -$33M192020: -$57M202021: -$42M212022: -$45M222023: -$21M232024: $54M242025: $145M25$145M
Free cash flow
2016: -$18M162017: -$16M172018: -$19M182019: -$36M192020: -$56M202021: -$25M212022: $2M222023: $1M232024: $91M242025: $78M25$78M
EPS (diluted)
2016: $-16.90162017: $-14.88172018: $-1.50182019: $-1.40192020: $-2.19202021: $-1.54212022: $-1.60222023: $-0.72232024: $1.75242025: $4.8925$4.89

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$881M$912M$803M$625M$408M$233M$115M$82M$51M$29M$16M
Gross profit$759M$779M$680M$528M$342M$200M$98M$68M$41M$23M$13M
Operating income$16M$51M$36M-$40M-$48M-$40M-$56M-$35M-$20M-$16M-$17M
Net income$101M$145M$54M-$21M-$45M-$42M-$57M-$33M-$22M-$18M-$19M
EPS (diluted)$3.36$4.89$1.75$-0.72$-1.60$-1.54$-2.19$-1.40$-1.50$-14.88$-16.90
R&D$98M$103M$114M$117M$69M$37M$26M$13M$7M$6M$7M
Revenue growth—+13.6%+28.5%+53.2%+74.8%+102.3%+40.6%+62.2%+77.1%+73.9%—

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$135M$117M$130M$25M$12M-$20M-$53M-$33M-$19M-$16M-$18M
Capital spending-$37M-$38M-$39M-$24M-$9M-$5M-$2M-$3M-$250000-$412000-$306000
Free cash flow$98M$78M$91M$1M$2M-$25M-$56M-$36M-$19M-$16M-$18M
Dividends paid—$0$0$0$0$0$0$0$0$0$0
Buybacks$50M$175M$0$0$0——————
Stock-based pay$117M$130M$116M$82M$52M$26M$13M$6M$1M$243000$248000

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$308M$446M$460M$451M$214M$234M$149M$188M$16M$7M
Debt—$32M$32M$25M$9M$34M$31M$25M$27M$16M—
Equity—$781M$690M$573M$496M$229M$230M$140M$164M$1M-$7M
Total assets—$907M$808M$677M$565M$295M$281M$181M$200M$25M—
Shares (diluted)29M30M31M29M28M27M26M24M15M1M1M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin86.2%85.4%84.7%84.5%83.8%85.7%84.7%83.4%80.1%78.9%76.2%
Operating margin1.8%5.6%4.5%-6.5%-11.7%-17.1%-48.7%-42.5%-40.3%-56.0%-105.0%
Net margin11.4%16.0%6.7%-3.4%-11.0%-18.0%-49.6%-40.5%-43.1%-61.3%-112.8%
FCF margin11.1%8.6%11.3%0.2%0.6%-10.6%-48.1%-43.4%-37.4%-56.7%-111.1%
ROIC—5.0%4.6%-5.3%-7.4%-12.0%-17.1%-16.7%-10.7%-90.0%—
ROE—18.6%7.8%-3.7%-9.0%-18.4%-24.9%-23.8%-13.3%-1319.6%280.4%

Frequently asked questions

What is Inspire Medical Systems’s annual revenue?

$912M in fiscal 2025 and $881M over the twelve months to September 30, 2026.

How much profit does Inspire Medical Systems make?

Net income was $145M in fiscal 2025 (net margin 15.9%).

Is Inspire Medical Systems’s revenue growing?

Yes: revenue rose 13.6% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.